Emerging Infections Programs (EIP)
Expiration Date: 4/30/2022
Program Contact
Sonja Mali Nti-Berko
Emerging Infections Programs (EIP)
Division of Preparedness and Emerging Infections
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
1600 Clifton Rd, MS-C18
Atlanta, GA 30329
Phone: (404) 488-4780
E-mail: [email protected]
Submission Date: November 23, 2020
Table of Contents and Attachments
Non-Substantive Change Request Justification Document
Description of Changes (Att 1)
Cross-Walk (Att 2)
HAIC: Resistant Gram-Negative Bacilli (MuGSI) Case Report Form for Carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii (Att 3)
HAIC: Multi-site Gram-Negative Surveillance Initiative (MuGSI)- Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (ESBL) (Att. 4)
HAIC: Annual Survey of Laboratory Testing Practices for C. difficile Infections (Att. 5)
Justification for Change Request for OMB 0920-0978
This is a nonmaterial/non-substantive change request for OMB No. 0920-0978, expiration date 05/31/2021, for the Emerging Infections Programs (EIP). All requested changes represent minor modifications to already-approved instruments including revised formatting, rewording, new answer options, and the addition/subtraction of a limited number of questions.
The Emerging Infections Programs (EIPs) are population-based centers of excellence established through a network of state health departments collaborating with academic institutions, local health departments, public health and clinical laboratories, infection control professionals, and healthcare providers. EIPs assist in local, state, and national efforts to prevent, control, and monitor the public health impact of infectious diseases.
Activities of the EIPs fall into the following general categories: (1) active surveillance; (2) applied public health epidemiologic and laboratory activities; (3) implementation and evaluation of pilot prevention/intervention projects; and (4) flexible response to public health emergencies. Activities of the EIPs are designed to: (1) address issues that the EIP network is particularly suited to investigate; (2) maintain sufficient flexibility for emergency response and new problems as they arise; (3) develop and evaluate public health interventions to inform public health policy and treatment guidelines; (4) incorporate training as a key function; and (5) prioritize projects that lead directly to the prevention of disease.
Activities in the EIP Network in which all applicants must participate are:
Active Bacterial Core surveillance (ABCs): active population-based laboratory surveillance for invasive bacterial diseases.
Foodborne Diseases Active Surveillance Network (FoodNet): active population-based laboratory surveillance to monitor the incidence of select enteric diseases.
Influenza Hospitalization Surveillance Network (FluSurv-NET): active population-based surveillance for laboratory confirmed influenza-related hospitalizations.
Healthcare-Associated Infections-Community Interface (HAIC) surveillance: active population-based surveillance for healthcare-associated pathogens and infections.
This non-substantive change request is for changes to the disease-specific data elements for only HAIC. The changes made to the all forms under this non-substantive request will aid in improving surveillance efficiency and data quality to clarify the burden of disease and possible risk factors for disease. This information can be used to inform strategies for preventing disease and negative outcomes. Specifically, changes were made for clarification purposes, to assist data collectors in capturing data in a standardized fashion to improve accuracy. As a result of proposed changes, the estimated annualized burden is expected to increase by 11 hours, from 38,883 to 38,894. The data elements and justifications are described below.
The forms for which approval for changes are being sought include:
HAIC:
Resistant Gram-Negative Bacilli (MuGSI) Case Report Form for Carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii (Attachment 3)
2020 Multi-site Gram-Negative Surveillance Initiative (MuGSI)- Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (ESBL) (Attachment 4)
Annual Survey of Laboratory Testing Practices for C. difficile Infections (Attachment 5)
The changes for Resistant Gram-Negative Bacilli (MuGSI) Case Report Form for Carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii (Attachment 3) and
2020 Multi-site Gram-Negative Surveillance Initiative (MuGSI)- Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (ESBL) (Attachment 4) will be effective and implemented on 01/01/2021. The Annual Survey of Laboratory Testing Practices for C. difficile Infections (Attachment 5) will be administered in 2021.
Estimated Annualized Burden Hours
As a result of proposed changes to forms highlighted in yellow, the estimated annualized burden is expected to increase by11 hours, from 38,883 to 38,894.
The following table is updated for the entire 0920-0978 burden table. The forms included in this change request are highlighted:
Type of Respondent |
Form Name |
No. of respondents |
No. of responses per respondent (Current) |
Avg. burden per response (in hours) (Current) |
Avg. burden per response (in hours) (After Changes) |
Current Proposed Changes |
After Proposed Changes |
State Health Department
|
ABCs Case Report Form |
10 |
809 |
20/60 |
|
2697 |
2697 |
ABCs Invasive Pneumococcal Disease in Children Case Report Form |
10 |
22 |
10/60 |
|
37 |
37 |
|
ABCs H. influenzae Neonatal Sepsis Expanded Surveillance Form |
10 |
6 |
10/60 |
|
10 |
10 |
|
ABCs Severe GAS Infection Supplemental Form |
10 |
136 |
20/60 |
|
453 |
453 |
|
ABCs Neonatal Infection Expanded Tracking Form |
10 |
37 |
20/60 |
|
123 |
123 |
|
FoodNet Campylobacter |
10 |
970 |
21/60 |
|
3395 |
3395 |
|
FoodNet Cyclospora |
10 |
42 |
10/60 |
|
70 |
70 |
|
FoodNet Listeria monocytogenes |
10 |
16 |
20/60 |
|
53 |
53 |
|
FoodNet Salmonella |
10 |
855 |
21/60 |
|
2993 |
2993 |
|
FoodNet Shiga toxin producing E. coli |
10 |
290 |
20/60 |
|
967 |
967 |
|
FoodNet Shigella |
10 |
234 |
10/60 |
|
390 |
390 |
|
FoodNet Vibrio |
10 |
46 |
10/60 |
|
77 |
77 |
|
FoodNet Yersinia |
10 |
55 |
10/60 |
|
92 |
92 |
|
FoodNet Hemolytic Uremic Syndrome |
10 |
10 |
1 |
|
100 |
100 |
|
FoodNet Clinical Laboratory Practices and Testing Volume |
10 |
70 |
20/60 |
|
233 |
233 |
|
FluSurv-Net Influenza Hospitalization Surveillance Network Case Report Form |
10 |
977 |
17/60 |
|
2768 |
2768 |
|
FluSurv-Net Influenza Hospitalization Surveillance Project Vaccination Phone Script Consent Form (English) |
10 |
333 |
5/60 |
|
278 |
278 |
|
FluSurv-Net Influenza Hospitalization Surveillance Project Vaccination Phone Script Consent Form (Spanish) |
10 |
333 |
5/60 |
|
278 |
278 |
|
FluSurv-Net Influenza Hospitalization Surveillance Project Provider Vaccination History Fax Form (Children/Adults) |
10 |
333 |
5/60 |
|
278 |
278 |
|
FluSurv-NET Laboratory Survey |
10 |
23 |
10/60 |
|
38 |
38 |
|
HAIC - MuGSI Case Report Form for Carbapenem-resistant Enterobacteriaceae (CRE) and Acinetobacter baumannii (CRAB) |
10 |
500 |
28/60 |
|
2333 |
2333 |
|
HAIC - MuGSI Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (ESBL) |
10 |
1104 |
28/60 |
|
5152 |
5152 |
|
HAIC - Invasive Methicillin-resistant Staphylococcus aureus (MRSA) Infection Case Report Form |
10 |
340
|
28/60
|
|
1587 |
1587 |
|
HAIC - Invasive Methicillin-sensitive Staphylococcus aureus (MSSA) Infection Case Report Form |
10 |
584
|
28/60
|
|
2725 |
2725 |
|
HAIC - CDI Case Report and Treatment Form |
10 |
1650 |
38/60 |
|
10450 |
10450 |
|
HAIC Candidemia Case Report |
10 |
170 |
40/60 |
|
1134 |
1134 |
|
HAIC- Annual Survey of Laboratory Testing Practices for C. difficile Infections. |
10 |
16 |
15/60 |
19/60 |
40 |
51 |
|
HAIC- CDI Annual Surveillance Officers Survey |
10 |
1 |
15/60 |
|
3 |
3 |
|
HAIC- Emerging Infections Program C. difficile Surveillance Nursing Home Telephone Survey (LTCF) |
10 |
45 |
5/60 |
|
38 |
38 |
|
HAIC- Invasive Staphylococcus aureus Laboratory Survey: Use of Nucleic Acid Amplification Testing (NAAT) |
10 |
11 |
20/60 |
|
37 |
37 |
|
HAIC- Invasive Staphylococcus aureus Supplemental Surveillance Officers Survey |
10 |
1 |
10/60 |
|
17 |
17 |
|
HAIC- Laboratory Testing Practices for Candidemia Questionnaire |
10 |
20 |
11/60 |
|
37 |
37 |
|
TOTAL |
|
|
38,883 |
38,894 |
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Title | OMB CY 08 |
Author | wsb2 |
File Modified | 0000-00-00 |
File Created | 2021-01-12 |